Lawyer Aaron Siri from the Siri and Glimstad LLP shared a letter from the FDA directed to a redacted person saying that one package with Ivermectin will be held from delivery.
“The FDA is working with the post office to hold packages containing ivermectin,” Siri tweeted. “The FDA could better use its resources to, I don’t know, publicly release the docs submitted by Pfizer to license its mandated liability-free V earlier than 75 years from now!”
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
Siri referred to the FDA and asked the courts to give them till 2076 to release the documents given by Pfizer to obtain a license for the use of its shot for C-19.
You can read the full letter here.
The policy says, “[I]n most circumstances, [it is] illegal for individuals to import drugs or devices into the U.S. for personal use because these products purchased from other countries often have not been approved by the FDA for use and sale in the U.S. For example, a drug approved for use in another country but not approved by the FDA would be considered an unapproved drug in the U.S. and, therefore, illegal to import.”
UncoverDC reported, “The FDA says it cannot guarantee the ‘safety and effectiveness of a medication purchased over the internet from a foreign country.”
The document also gives exceptions for the rule of Ivermectin given its profile and its lack of availability in the USA because of the drug rejection.
Ivermectin is a drug that successfully treated C-19 patients. The U.S. National Library of Medicine listed 80 studies showing the drug’s effectiveness when fighting C-19.
The FDA started a campaign against the Nobel-Prize winning drug, and non-government-run sources like the American Journal of Therapeutics shared the Ivermectin effectiveness.
Many other countries approved the drug usage and have seen major success in using it.